Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.09
MRGE's Cash to Debt is ranked lower than
64% of the 1672 Companies
in the Global Health Information Services industry.

( Industry Median: 22.71 vs. MRGE: 0.09 )
MRGE' s 10-Year Cash to Debt Range
Min: 0.07   Max: No Debt
Current: 0.09

Equity to Asset 0.13
MRGE's Equity to Asset is ranked lower than
62% of the 1618 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. MRGE: 0.13 )
MRGE' s 10-Year Equity to Asset Range
Min: 0.1   Max: 0.94
Current: 0.13

0.1
0.94
Interest Coverage 0.45
MRGE's Interest Coverage is ranked lower than
66% of the 1026 Companies
in the Global Health Information Services industry.

( Industry Median: 690.23 vs. MRGE: 0.45 )
MRGE' s 10-Year Interest Coverage Range
Min: 0.2   Max: 9999.99
Current: 0.45

0.2
9999.99
F-Score: 3
Z-Score: -1.46
M-Score: -2.91
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 4.23
MRGE's Operating margin (%) is ranked higher than
66% of the 1586 Companies
in the Global Health Information Services industry.

( Industry Median: 5.71 vs. MRGE: 4.23 )
MRGE' s 10-Year Operating margin (%) Range
Min: -339.18   Max: 17.53
Current: 4.23

-339.18
17.53
Net-margin (%) -16.83
MRGE's Net-margin (%) is ranked lower than
54% of the 1585 Companies
in the Global Health Information Services industry.

( Industry Median: 3.83 vs. MRGE: -16.83 )
MRGE' s 10-Year Net-margin (%) Range
Min: -348.38   Max: 18.05
Current: -16.83

-348.38
18.05
ROE (%) -86.98
MRGE's ROE (%) is ranked lower than
62% of the 1548 Companies
in the Global Health Information Services industry.

( Industry Median: 6.84 vs. MRGE: -86.98 )
MRGE' s 10-Year ROE (%) Range
Min: -703   Max: 20.6
Current: -86.98

-703
20.6
ROA (%) -10.19
MRGE's ROA (%) is ranked lower than
54% of the 1603 Companies
in the Global Health Information Services industry.

( Industry Median: 3.56 vs. MRGE: -10.19 )
MRGE' s 10-Year ROA (%) Range
Min: -278.36   Max: 13.32
Current: -10.19

-278.36
13.32
ROC (Joel Greenblatt) (%) 206.94
MRGE's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 1584 Companies
in the Global Health Information Services industry.

( Industry Median: 34.63 vs. MRGE: 206.94 )
MRGE' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -6398.15   Max: 261.74
Current: 206.94

-6398.15
261.74
Revenue Growth (%) 12.20
MRGE's Revenue Growth (%) is ranked higher than
81% of the 1368 Companies
in the Global Health Information Services industry.

( Industry Median: 6.20 vs. MRGE: 12.20 )
MRGE' s 10-Year Revenue Growth (%) Range
Min: -28.7   Max: 36.1
Current: 12.2

-28.7
36.1
EBITDA Growth (%) -37.00
MRGE's EBITDA Growth (%) is ranked lower than
55% of the 1102 Companies
in the Global Health Information Services industry.

( Industry Median: 7.70 vs. MRGE: -37.00 )
MRGE' s 10-Year EBITDA Growth (%) Range
Min: -37   Max: 97.6
Current: -37

-37
97.6
EPS Growth (%) 3.40
MRGE's EPS Growth (%) is ranked higher than
66% of the 1059 Companies
in the Global Health Information Services industry.

( Industry Median: 7.50 vs. MRGE: 3.40 )
MRGE' s 10-Year EPS Growth (%) Range
Min: 0   Max: 170.5
Current: 3.4

0
170.5
» MRGE's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

MRGE Guru Trades in Q2 2013

Joel Greenblatt 230,773 sh (+62.95%)
Jim Simons Sold Out
Steven Cohen Sold Out
» More
Q3 2013

MRGE Guru Trades in Q3 2013

Joel Greenblatt 229,783 sh (-0.43%)
» More
Q4 2013

MRGE Guru Trades in Q4 2013

Paul Tudor Jones 27,596 sh (New)
Joel Greenblatt 117,280 sh (-48.96%)
» More
Q1 2014

MRGE Guru Trades in Q1 2014

Paul Tudor Jones 27,596 sh (unchged)
Joel Greenblatt Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MRGE

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-03-31 Sold Out 0.01%$2.04 - $2.79 $ 2.422%0
Joel Greenblatt 2013-12-31 Reduce -48.96%0.01%$2.15 - $2.78 $ 2.420%117280
Joel Greenblatt 2013-06-30 Add 62.95%0.01%$2.91 - $3.67 $ 2.42-26%230773
Joel Greenblatt 2013-03-31 Add 144.05%0.01%$2.35 - $2.97 $ 2.42-9%141623
John Burbank 2012-12-31 Sold Out 0.04%$2.45 - $3.79 $ 2.42-23%0
Joel Greenblatt 2012-12-31 New Buy0.01%$2.45 - $3.79 $ 2.42-23%58031
John Burbank 2012-09-30 New Buy0.04%$2.87 - $4 $ 2.42-26%250000
Joel Greenblatt 2012-09-30 Sold Out 0.02%$2.87 - $4 $ 2.42-26%0
Joel Greenblatt 2012-03-31 Add 151.43%0.02%$4.54 - $6.76 $ 2.42-56%79092
Joel Greenblatt 2011-12-31 New Buy0.02%$4.4 - $6.95 $ 2.42-58%31457
George Soros 2011-06-30 Sold Out $4.69 - $6.07 $ 2.42-54%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Merge Healthcare Inc

Sector Watch: Application Software, Billionaires Hold Stocks on the Fringe
The application software industry currently lists a total of 257 stocks, with only seven stocks on a 52-week low. The sector low ratio is 0.03. Read more...

Ratios

vs
industry
vs
history
P/B 5.10
MRGE's P/B is ranked higher than
56% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 3.00 vs. MRGE: 5.10 )
MRGE' s 10-Year P/B Range
Min: 0.56   Max: 19.39
Current: 5.1

0.56
19.39
P/S 1.04
MRGE's P/S is ranked higher than
80% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 2.42 vs. MRGE: 1.04 )
MRGE' s 10-Year P/S Range
Min: 0.24   Max: 11.94
Current: 1.04

0.24
11.94
PFCF 11.40
MRGE's PFCF is ranked higher than
92% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 146.80 vs. MRGE: 11.40 )
MRGE' s 10-Year PFCF Range
Min: 9.86   Max: 280
Current: 11.4

9.86
280
EV-to-EBIT 48.90
MRGE's EV-to-EBIT is ranked higher than
65% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 33.52 vs. MRGE: 48.90 )
MRGE' s 10-Year EV-to-EBIT Range
Min: 12.8   Max: 1533.3
Current: 48.9

12.8
1533.3
Current Ratio 1.09
MRGE's Current Ratio is ranked lower than
55% of the 1648 Companies
in the Global Health Information Services industry.

( Industry Median: 1.92 vs. MRGE: 1.09 )
MRGE' s 10-Year Current Ratio Range
Min: 0.64   Max: 6.5
Current: 1.09

0.64
6.5
Quick Ratio 1.02
MRGE's Quick Ratio is ranked lower than
54% of the 1648 Companies
in the Global Health Information Services industry.

( Industry Median: 1.80 vs. MRGE: 1.02 )
MRGE' s 10-Year Quick Ratio Range
Min: 0.42   Max: 5.88
Current: 1.02

0.42
5.88

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 2.80
MRGE's Price/DCF (Projected) is ranked higher than
80% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. MRGE: 2.80 )
MRGE' s 10-Year Price/DCF (Projected) Range
Min: 0.93   Max: 26.64
Current: 2.8

0.93
26.64
Price/Median PS Value 0.40
MRGE's Price/Median PS Value is ranked higher than
97% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 1.20 vs. MRGE: 0.40 )
MRGE' s 10-Year Price/Median PS Value Range
Min: 0.1   Max: 4.98
Current: 0.4

0.1
4.98
Earnings Yield (Greenblatt) 1.90
MRGE's Earnings Yield (Greenblatt) is ranked lower than
52% of the 1384 Companies
in the Global Health Information Services industry.

( Industry Median: 5.60 vs. MRGE: 1.90 )
MRGE' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 7.8
Current: 1.9

0.1
7.8
Forward Rate of Return (Yacktman) -5.89
MRGE's Forward Rate of Return (Yacktman) is ranked higher than
51% of the 1188 Companies
in the Global Health Information Services industry.

( Industry Median: 5.80 vs. MRGE: -5.89 )
MRGE' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -14.4   Max: 5.2
Current: -5.89

-14.4
5.2

Business Description

Industry: Application Software » Health Information Services
Compare:CERN, CTRX, ATHN, MDRX, AH » details
Traded in other countries:MRJ.Germany
Merge Healthcare Inc., was founded in 1987 and is incorporated in Delaware. The Company develops software solutions that facilitate the sharing of images to create a more effective and efficient electronic healthcare experience for patients and physicians. Its solutions are designed to help solve some of the difficult challenges in health information exchange today, such as the incorporation of medical images and diagnostic information into broader healthcare IT applications, the interoperability of proprietary software solutions, and the ability to improve the efficiency and cost effectiveness of its customers' businesses. The Company's solutions optimize processes for healthcare providers ranging in size from single provider practices to large health systems, to the sponsors of clinical trials and medical device manufacturers. These solutions are licensed by more than 1,500 hospitals, 6,000 clinics and labs, 250 medical device manufacturers and by top pharmaceutical companies. It operates in two reportable segments: Merge Healthcare mainly generates revenue from the sale of software (including upgrades); hardware, professional services, maintenance and electronic data interchange (EDI) services. Merge DNA derives the vast majority of its revenue from software, professional services and hosting through subscription arrangements. Its product portfolio provide a range of products and services to its customers, including Image Interoperability Platform - iConnect: This interoperability and connectivity platform enables hospitals, imaging centers, Integrated Delivery Networks and Health Information Exchanges to create information exchanges within their environments and with other entities.,Clinical and Financial Information Systems - Digital Imaging Solutions: Picture Archiving and Communication Systems (PACS), specialty workstations and related applications manage the image workflow of a medical enterprise; Clinical information systems: These systems provide a complete electronic record of a medical procedure across a variety of specialties - including Merge OrthoEMR for orthopaedics, and Merge RIS for radiology; Revenue Cycle Management: It offer software and services for the revenue cycle management of physician practices, Software Development Toolkits, Technologies and Platforms - Merge toolkits, technologies and platforms provide software developers with the necessary resources to assist in the timely development of new products and enhance existing products and Hosted Software Solutions for Clinical Trial Data Management - It provide hosted software solutions for the collection, aggregation, analysis, reporting and overall management of clinical trials information. Its strategy is to be a provider of integrated, global healthcare IT solutions and services that improve the exchange of healthcare information. It is subject to regulation in the U.S. by the Food and Drug Administration (FDA), including periodic FDA inspections, in
» More Articles for MRGE

Headlines

Articles On GuruFocus.com
Weekly Three-Year Low Highlights: AGI, ARO, WTSL, MRGE Jan 20 2014 
Sector Watch: Application Software, Billionaires Hold Stocks on the Fringe Dec 29 2013 
2.45 Mar 26 2013 
Merge Technologies Inc. (MRGE) CFO & Treasurer Steven M Oreskovich sells 19,000 Shares Dec 20 2010 
Merge Technologies Inc. Reports Operating Results (10-K/A) Aug 26 2010 
Merge Healthcare Acquisition of Confirma Complete Sep 01 2009 
Merge Healthcare Set to Acquire Confirma Aug 07 2009 
Merge Healthcare Reports Best Operating Income in Three Years Jul 30 2009 
Merge Healthcare Announces Second Straight Quarter of Topline Revenue and EPS Growth Feb 12 2009 
Merge Healthcare Sets Fourth Quarter Earnings Call Date Jan 29 2009 

More From Other Websites
Merge Sets Second Quarter 2014 Earnings Call Jul 23 2014
Merge Sets Second Quarter 2014 Earnings Call Jul 23 2014
Merge Healthcare: Updated Research Report Jun 20 2014
MERGE HEALTHCARE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 19 2014
Merge Receives Healthcare Informatics' Most Interesting Vendor Honor and Top 100 Ranking May 29 2014
Eurotrials Selects Merge eClinical as Clinical Research Technology Partner May 19 2014
Merge Clarifies Purpose of Recent Trading Activity May 15 2014
Health Care IT Stock Picks: A Wall Street Transcript Interview with Garen Sarafian, Citigroup... May 12 2014
MERGE HEALTHCARE INC Financials May 09 2014
MERGE HEALTHCARE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of... May 05 2014
Advanced Data Systems and Merge Healthcare Partner to Provide Optimized Interoperability for... May 02 2014
Merge Healthcare Misses on Q1 Revs, Cuts 2014 Earnings View May 01 2014
Merge Healthcare Incorporated Management Discusses Q1 2014 Results - Earnings Call Transcript Apr 30 2014
Q1 2014 Merge Healthcare, Inc. Earnings Release - Before Market Open Apr 30 2014
MERGE HEALTHCARE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 30 2014
Merge Reports First Quarter Financial Results Apr 30 2014
iConnect(R) Network Gains Momentum With 19 Contracts in First Quarter Apr 28 2014
Merge Healthcare to Launch New Retinal Screening Solution for Advanced Interoperability, Enhanced... Apr 24 2014
Merge Healthcare to Launch New Retinal Screening Solution for Advanced Interoperability, Enhanced... Apr 24 2014
Updated Research Report on Merge Mar 27 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide